Literature DB >> 10354616

The interactions of adenylate cyclases with P-site inhibitors.

C W Dessauer1, J J Tesmer, S R Sprang, A G Gilman.   

Abstract

Recent kinetic, binding and crystallographic studies using P-site inhibitors of mammalian adenylate bases provide new insights into the catalytic mechanism of these highly regulated enzymes. Here, Carmen Dessauer and colleagues discuss the conformational states of adenylate cyclase, the structural determinants of inhibitor binding and the potential uses of these inhibitors as pharmacological agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10354616     DOI: 10.1016/s0165-6147(99)01310-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  29 in total

1.  Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism.

Authors:  I Ruiz-Stewart; S R Tiyyagura; J E Lin; S Kazerounian; G M Pitari; S Schulz; E Martin; F Murad; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-18       Impact factor: 11.205

Review 2.  Molecular details of cAMP generation in mammalian cells: a tale of two systems.

Authors:  Margarita Kamenetsky; Sabine Middelhaufe; Erin M Bank; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

3.  Regulation of type V adenylate cyclase by Ric8a, a guanine nucleotide exchange factor.

Authors:  Shyi-Chyi Wang; Hsing-Lin Lai; Yi-Ting Chiu; Ren Ou; Chuen-Lin Huang; Yijuang Chern
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

Review 4.  New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications.

Authors:  John Garthwaite
Journal:  Mol Cell Biochem       Date:  2009-12-11       Impact factor: 3.396

5.  Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate.

Authors:  Silke Kleinboelting; Ana Diaz; Sebastien Moniot; Joop van den Heuvel; Michael Weyand; Lonny R Levin; Jochen Buck; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-24       Impact factor: 11.205

6.  Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.

Authors:  Melanie Hübner; Sara Dizayee; Jan Matthes; Roland Seifert; Stefan Herzig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-04-12       Impact factor: 3.000

7.  A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.

Authors:  Clemens Steegborn; Tatiana N Litvin; Kenneth C Hess; Austin B Capper; Ronald Taussig; Jochen Buck; Lonny R Levin; Hao Wu
Journal:  J Biol Chem       Date:  2005-07-07       Impact factor: 5.157

8.  A new site and mechanism of action for the widely used adenylate cyclase inhibitor SQ22,536.

Authors:  Andrew C Emery; Maribeth V Eiden; Lee E Eiden
Journal:  Mol Pharmacol       Date:  2012-10-10       Impact factor: 4.436

Review 9.  Inhibitors of membranous adenylyl cyclases.

Authors:  Roland Seifert; Gerald H Lushington; Tung-Chung Mou; Andreas Gille; Stephen R Sprang
Journal:  Trends Pharmacol Sci       Date:  2011-11-17       Impact factor: 14.819

10.  Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds.

Authors:  Cameron S Brand; Harrison J Hocker; Alemayehu A Gorfe; Claudio N Cavasotto; Carmen W Dessauer
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.